MX2022003427A - Particulas portadoras novedosas para formulaciones de polvo seco para inhalacion. - Google Patents

Particulas portadoras novedosas para formulaciones de polvo seco para inhalacion.

Info

Publication number
MX2022003427A
MX2022003427A MX2022003427A MX2022003427A MX2022003427A MX 2022003427 A MX2022003427 A MX 2022003427A MX 2022003427 A MX2022003427 A MX 2022003427A MX 2022003427 A MX2022003427 A MX 2022003427A MX 2022003427 A MX2022003427 A MX 2022003427A
Authority
MX
Mexico
Prior art keywords
inhalation
dry powder
carrier particles
powder formulations
novel carrier
Prior art date
Application number
MX2022003427A
Other languages
English (en)
Inventor
Andrea Benassi
Tomaso Guidi
Original Assignee
Chiesi Farm Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farm Spa filed Critical Chiesi Farm Spa
Publication of MX2022003427A publication Critical patent/MX2022003427A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Otolaryngology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invención se refiere a partículas portadoras para formulaciones de polvo seco para inhalación y un proceso para la preparación de las mismas.
MX2022003427A 2019-09-24 2020-09-22 Particulas portadoras novedosas para formulaciones de polvo seco para inhalacion. MX2022003427A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP19199337 2019-09-24
PCT/EP2020/076369 WO2021058454A1 (en) 2019-09-24 2020-09-22 Novel carrier particles for dry powder formulations for inhalation

Publications (1)

Publication Number Publication Date
MX2022003427A true MX2022003427A (es) 2022-04-18

Family

ID=68066683

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022003427A MX2022003427A (es) 2019-09-24 2020-09-22 Particulas portadoras novedosas para formulaciones de polvo seco para inhalacion.

Country Status (10)

Country Link
US (1) US20220331244A1 (es)
EP (1) EP4034079A1 (es)
JP (1) JP2022549445A (es)
KR (1) KR20220066906A (es)
CN (1) CN114514020A (es)
AU (1) AU2020356243A1 (es)
BR (1) BR112022004970A2 (es)
CA (1) CA3150240A1 (es)
MX (1) MX2022003427A (es)
WO (1) WO2021058454A1 (es)

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4140689B4 (de) 1991-12-10 2007-11-22 Boehringer Ingelheim Kg Inhalationspulver und Verfahren zu ihrer Herstellung
IS1736B (is) * 1993-10-01 1999-12-30 Astra Ab Aðferð og tæki sem stuðla að aukinni samloðun agna
GB9404945D0 (en) 1994-03-15 1994-04-27 Glaxo Group Ltd Pharmaceutical composition
DE4425255A1 (de) 1994-07-16 1996-01-18 Asta Medica Ag Formulierung zur inhalativen Applikation
SE9700134D0 (sv) 1997-01-20 1997-01-20 Astra Ab New formulation
GB9501841D0 (en) 1995-01-31 1995-03-22 Co Ordinated Drug Dev Improvements in and relating to carrier particles for use in dry powder inhalers
SE9700133D0 (sv) 1997-01-20 1997-01-20 Astra Ab New formulation
GB9826783D0 (en) 1998-12-04 1999-01-27 Scherer Ltd R P Inhalation powders
PE20011227A1 (es) 2000-04-17 2002-01-07 Chiesi Farma Spa Formulaciones farmaceuticas para inhaladores de polvo seco en la forma de aglomerados duros
GB0012260D0 (en) 2000-05-19 2000-07-12 Astrazeneca Ab Novel composition
GB0012261D0 (en) 2000-05-19 2000-07-12 Astrazeneca Ab Novel process
EP1386630B1 (en) 2002-07-31 2006-05-17 CHIESI FARMACEUTICI S.p.A. Powder inhaler
GB0613161D0 (en) * 2006-06-30 2006-08-09 Novartis Ag Organic Compounds
EP2762133A1 (en) 2010-04-01 2014-08-06 CHIESI FARMACEUTICI S.p.A. Process for preparing carrier particles for dry powders for inhalation
NO2560611T3 (es) 2010-04-21 2018-06-02
AR087841A1 (es) 2011-09-14 2014-04-23 Chiesi Farma Spa Derivados de tetrahidrotriazolopirimidina
ES2938466T3 (es) 2012-01-25 2023-04-11 Chiesi Farm Spa Formulación en polvo seco que comprende un corticoesteroide y un beta-adrenérgico para administración por inhalación
CN104870449B (zh) 2012-12-18 2018-11-06 奇斯药制品公司 化合物
UA116907C2 (uk) 2013-07-11 2018-05-25 К'Єзі Фармачеутічі С.П.А. Композиція у вигляді сухого порошку, яка містить антихолінергічний, кортикостероїдний та бета-адренергічний засіб, для інгаляцій
TWI672297B (zh) 2013-12-18 2019-09-21 義大利商吉斯藥品公司 作為磷脂肌醇－３－激酶抑制劑之異唏衍生物
EP3505209B1 (en) 2014-06-30 2020-11-18 Chiesi Farmaceutici S.p.A. Powder inhaler

Also Published As

Publication number Publication date
CA3150240A1 (en) 2021-04-01
JP2022549445A (ja) 2022-11-25
WO2021058454A1 (en) 2021-04-01
BR112022004970A2 (pt) 2022-08-23
US20220331244A1 (en) 2022-10-20
EP4034079A1 (en) 2022-08-03
AU2020356243A1 (en) 2022-03-24
KR20220066906A (ko) 2022-05-24
CN114514020A (zh) 2022-05-17

Similar Documents

Publication Publication Date Title
MX2012012045A (es) Proceso para proporcionar particulas con cargas electrostaticas reducidas.
MX2020005995A (es) Mezcla secada por atomizacion de oligosacaridos de leche humana.
PH12017500762A1 (en) Proflavor delivery particles
MX336414B (es) Proceso de preparacion de particulas portadoras para polvos secos para inhalacion.
MX2019004322A (es) Polvos secos antifungicos.
PH12018501199A1 (en) Nicotine particle capsule
TN2016000527A1 (en) Dry powder inhaler and inhalation actuated mechanism thereof
MX2018015118A (es) Particulas y composiciones de nicotina.
JOP20210305A1 (ar) صيغ إيماتينيب وتصنيعها واستخداماتها
MX2017008390A (es) Uretanos funcionalizados con alcoxisilano y funcionalizados con alofanato.
ZA202106602B (en) Claudin 6 antibodies and uses thereof
WO2020104970A3 (en) Multi-layered particles
MX2018006348A (es) Apuntalantes de peso ligero y metodos para hacer y usar los mismos.
MX2020005876A (es) Composicion que comprende gliceridos de acidos grasos en polvo.
MX2020003761A (es) Particulas solidas de simeticona y forma de dosificacion de estas.
ZA202106206B (en) Fertilizer particles comprising iron
MX2022003427A (es) Particulas portadoras novedosas para formulaciones de polvo seco para inhalacion.
IN2014MU00626A (es)
PL3621682T3 (pl) Inhalator suchego proszku
EP3600366A4 (en) PROCESS FOR THE PREPARATION OF PROBIOTIC POWDER FORMULATIONS FOR MONOGASTRIC ANIMALS
EP3668822A4 (en) PROCESS FOR PREPARING IMPROVED 3,4-DIMETHYL-1H-PYRAZOLE PHOSPHATE FORMULATIONS
EP3463378A4 (en) DRY POWDER FORMULAS FOR INHALATION
MX2021000779A (es) Nuevas particulas portadoras para formulaciones de polvo seco para inhalacion.
MX2021012967A (es) Anticuerpos y formulaciones de anti-cd38.
EP4056299A4 (en) POWDERED MATERIAL